The availability of high quality resources and most experienced cancer surgeons in India makes chronic leukaemia surgery now possible in India at low risk and at very less cost. The cancer research centers in India are inventing various new surgical techniques for the treatment of cancer. New techniques invented by the cancer research center of India are according to the requirement of the cancer patients so that the cancer operation becomes risk free. The medical treatment centers for cancer surgery in India provide treatment to abroad patients at very less price as compared to the cost of abroad cancer surgery hospitals of abroad. Different cancer treatment centers for cancer surgery in India are at Delhi, Chennai, Calcutta, Hyderabad and Mumbai. Cancer surgeries in India have produced very good success rates of cure of cancer, with cancer surgery in India, the cancer can be cured completely at very low risk as the treatment is provided to patients from most experienced cancer surgeons of India. The advancement of surgical techniques reduces the recovery time after the surgery; patients can start doing their daily routine work within fifteen days after cancer surgery in India. Because of low cost of cancer treatment and availability of experienced surgeons in India, Indian cancer treatment centers becoming more popular in abroad countries, many abroad patients gets attracted to India for low cost cancer treatment in India.

Leukemia literally means ‘many white cells in the blood’. The white cells are part of the body’s immune system, and there are several sub-groups of white cells that have different sorts of roles in recognizing and dealing with ‘invaders’ such as bacteria and viruses as well as other types of foreign protein. All of the blood cells originate in the bone marrow and leukaemia which is also known as blood cancer is a disease where the bone marrow produces large numbers of abnormal white cells. This means that the normal marrow is pushed into smaller and smaller areas. This results in fewer normal cells being produced and gives rise to some of the symptoms. It is possible to have chronic leukemia for months or even years without knowing it. The symptoms are varied, but many people notice different symptoms like tiredness, bruising easily (often without having had any blow or fall), repeated infections, enlarged lymph glands, weight loss, night sweats, fever. These are most common symptoms appear when patient suffers from chronic leukemia. The surgical procedure of chronic leukemia surgery is very complex and it requires an experienced cancer surgeon for the treatment. There are many types of leukemia, each of which is classified according to the exact cell type affected by the disease. Chronic leukemia is a slowly progressive form of leukemia and tends to involve more mature cell types. It may not need treatment immediately, but if treatment is required it is usually chemotherapy, given in the form of tablets. The cause of leukemia is not known. Older people with early stage CLL have a normal life expectancy. Treatment in the form of chemotherapy will be required for those who are unwell or who have many enlarged lymph glands, or who become significantly anaemic. Chemotherapy is usually given in the form of tablets. Other chemotherapy drugs such as fludarabine may be used in late stage disease.

Medical tourism provides very good assistance to abroad patients in provision of best cancer treatment to patients. The ultimate aim of medical tourism in India is the provision of good treatment facilities to abroad patients for which they are coming India. Medical treatment centers for chronic leukemia surgery in India are at Delhi, Hyderabad, Mumbai, Nagpur and Bangalore. Medical tourism in India provides different low cost packages to abroad patients for their treatment in India. Low cost of cancer treatment and availability of most experienced cancer surgeons in India are the other reasons because of which Indian cancer surgery hospitals are becoming center of attraction now day’s. Many abroad patients are getting attracted to India for low cost chronic leukemia surgery cancer treatment in India.

Leukemia is generally considered and known as blood cancer, where as if considered in its real terms leukemia is a cancer of the white blood cells and the platelets. These platelets actually help blood to clot. Additionally when the white blood cells reduce in amount they actually leave the immune system unlocked for attack and the patient sometimes die of a very usual illness like flu. In general the deficiency of normal white cells impairs the body’s ability to struggle against infections. A shortage of platelets results in bruising and easy bleeding whenever there is a need of clot to stop the flow of blood.

All kinds of various acute or chronic diseases of leukemia are dangerous. Acute leukemia being a swiftly succeeding disease affects typically cells that are embryonic or primitive (which means the cells that have not yet fully developed or differentiated from the others). These not fully formed cells thus cannot achieve their standard utility. These cells are described as “nonfunctional” because they do not work like normal cells. They also number out the usual normal healthy cells in the marrow, resulting in a decrease in the number of new healthy normal cells made in the marrow. These later results in low red cell counts which is a typical form of anemia.

On the other hand chronic leukemia develops gradually, and allows the development of larger amounts of more developed cells. In broader perspective, these more grown-up cells can achieve some of their typical functionality but due to the increase in the number of cells like white blood cells the blood flow may slow down and result in severe anemia.

The leukemia is categorized in to four basic categories which are as follows:

o Acute Myelogenous Leukemia (AML)
o Acute Lymphocytic Leukemia (ALL)
o Chronic Myelogenous Leukemia (CML)
o Chronic Lymphocytic Leukemia (CLL)

For acute leukemia following are the signs and symptoms of leukemia:

o Fatigue or tiredness
o Shortness of breath during physical activity
o Sluggish curing of cuts and excess bleeding
o Mild fever or night sweats
o Black-and-blue spots (bruises) for no evident cause
o Pinhead-size red spots under the skin
o Pale skin
o Low white cell counts
o Aches in bones or joints

As far as chronic leukemia is concerned people with CLL or CML may not have any symptoms. Some patients learn they have CLL or CML after a blood test as part of a usual checkup. Occasionally, a person with CLL may see enlarged lymph nodes in the neck, armpit or groin and go to the doctor. The person may feel exhausted or short of breath or have frequent infections, if the CLL is more severe. In these cases, a blood test may show an increase in the lymphocyte count.

A comprehensive blood count is utilized to make a diagnosis of leukemia. This blood examination may confirm high or low point of white cells and show leukemic cells within the blood. Sometimes, number of platelet and red cell are fairly low. Bone marrow tests like aspiration and biopsy are often carried out to verify the analysis and to glance for any chromosome irregularities. All these tests spot the leukemia and its cell category. These tests must be continued after regular intervals after treatment commences to gauge how sound the healing is.

Problems of red cells, white cells, and platelets are separated for discussion because one or the other is discovered to become one of the most abnormal throughout laboratory testing. However, due to the clonal nature of hematopoiesis, numerous disorders affect all of the formed components from the blood.

This is possibly greatest demonstrated within the “blast crisis” phase of chronic myelogenous leukemia, by which the majority of both myeloid and lymphoid tissue in the blood may be shown to express an identical gene rearrangement, called bcr-abl or Philadelphia chromosome, that has arisen in a single abnormal progenitor cell.

Red Cellular Disorders:
There are many red cellular abnormalities, however the principal ones are a range of anemias. Anemia is defined as an abnormally low hemoglobin concentration in the bloodstream. You will find a number of techniques of classification, but the prevailing methods are based on red cellular dimension and form.

In normal persons, erythrocytes are of uniform dimension and shape, and the automated bloodstream count shows a mean corpuscular volume (MCV) near 90 fL, which is the estimated volume of a single cell. Automated methods usually report abnormalities of red tissue as changes in hemoglobin focus, red-colored cell amount, and MCV.

Small cells (with reduced MCVs) are termed microcytic, and tissue larger than typical are termed macrocytic. The relative nonuniformity of cellular shapes (poikilocytosis) or sizes (anisocytosis) can further aid in subclassifying erythrocyte disorders. In general, the microcytic anemias are due to abnormalities in hemoglobin manufacturing, either in quantity of hemoglobin molecules per cell or in type of hemoglobin molecules (hemoglobinopathies).

Iron deficiency anemia resulting from long-term bloodstream reduction and also the thalassemias are examples of microcytic anemia. The macrocytic anemias reflect either abnormal nuclear maturation or a greater fraction of youthful, large red tissue (reticulocytes). When the nuclei of maturing red tissue appear too young and big for the quantity of hemoglobin in the cytoplasm, the macrocytic anemia is termed megaloblastic.

These anemias are most often due possibly to vitamin deficiencies (vitamin B12 or folic acid) or medicines that interfere with DNA synthesis. Abnormal nuclear maturation can also be because of to clonal proliferation in the bone marrow, producing preleukemic states termed the myelodysplastic syndromes.

The normocytic anemias could be due to numerous causes: decreased numbers of red-colored cellular precursors in the marrow (primary failure called aplastic anemia, replacement of marrow components with cancer, certain viral infections, or autoimmune inhibition called pure red cell aplasia), low levels of erythropoietin (producing from long-term renal failure), or long-term inflammatory illnesses that affect the availability of iron within the marrow.

Other normocytic anemias could be secondary to decreased existence span from the cells that are created. Examples of this phenomenon are acute bloodstream loss; autoimmune hemolytic anemias, in which antibodies or complement bind to red-colored tissue and trigger their destruction; sickle cell anemia, in which the abnormal hemoglobin polymerizes and obliterates the usual resilience from the red-colored cell, and hereditary spherocytosis or hereditary elliptocytosis, by which defects in the erythrocyte membrane affect their capability to squeeze through the capillary microcirculation. Anemias are very typical.

In contrast, an elevated hemoglobin focus, termed erythrocytosis, is uncommon. Elevations in hemoglobin concentration can occur as a secondary phenomenon because of increased erythropoietin amounts, this kind of as that found in smokers or people who live at higher altitudes (whose reduced bloodstream oxygen levels stimulate erythropoietin manufacturing).

Some tumors, especially renal tumors, may also make erythropoietin. Main polycythemia is an abnormality from the bone marrow itself. This myeloproliferative syndrome leads to an elevated red-colored cellular mass and consequent reduced erythropoietin amounts through the negative-feedback mechanism discussed previously.

White Bloodstream Cellular Disorders:
Abnormalities in white cellular quantities occur generally, whereas abnormalities of function are rare. Neoplastic transformation within the form of leukemia (granulocytes and monocytes) or lymphoma (lymphocytes) is fairly typical.

Modifications in neutrophil be counted are the most typical white cellular abnormality detected about the automated bloodstream count. Elevated quantities of neutrophils (leukocytosis) suggest acute or long-term infection or inflammation but could be a sign of many conditions. These consist of stress, simply because adrenal corticosteroids cause demargination of neutrophils from bloodstream vessel walls.

Decreased quantities of neutrophils (neutropenia) can be seen in overwhelming infection and benign illnesses such as cyclic neutropenia (see later discussion) but may also be seen when the bone marrow is infiltrated with tumor or included through the myelodysplastic syndromes.

Numerous drugs can also immediately suppress marrow production, and simply because neutrophils have the shortest half-life in the blood of any cellular created through the marrow, their quantities may fall quickly. Lymphocyte quantities can vary substantially. Lymphocyte counts are classically elevated in viral infections, such as infectious mononucleosis.

However, persistent elevations suggest malignancies, especially chronic lymphocytic leukemia, which may not cause any symptoms and be incidentally discovered on a routine blood count. Reduced lymphocyte counts (lymphopenia) are a typical complication of corticosteroid therapy but are most worrisome for immunodeficiency states; HIV immediately infects lymphocytes, and the likelihood of opportunistic infections increases as lymphocyte counts fall, resulting in AIDS.

Platelet Disorders:
Abnormalities in platelet number are fairly typical, particularly low counts (thrombocytopenia). Reduced manufacturing of platelets occurs when the marrow is impacted by a range of diseases or when thrombopoietin production through the liver is impaired, as in cirrhosis. Increased destruction of platelets is much more prevalent.

There are 3 basic mechanisms. Simply because a substantial number of platelets normally reside in the spleen, any increase in spleen size or activity (hypersplenism) leads to reduced platelet counts. Platelet consumption due to ongoing clotting will also reduced counts. Most commonly, nevertheless, there is immune-mediated consumption triggered by either drugs or autoantibodies.

The latter are usually directed against the platelet membrane antigen gpIIb/IIIa. Functional platelet disorders are typical, particularly the acquired problems producing from uremia (renal failure) or aspirin, which inhibits the platelet enzyme cyclooxygenase and decreases platelet aggregability.

Inherited abnormalities are unusual with the exception of von Willebrand’s illness, which results from either quantitative or qualitative defect of von Willebrand factor, the carrier protein for element VIII. This factor also acts being a bridge in between platelets and also the endothelium and thus is essential for formation from the platelet plug in the coagulation cascade.

Elevations within the platelet be counted above typical (thrombocytosis) are fairly typical and are especially apt to happen in recovery from iron deficiency anemia upon iron repletion. Within the myeloproliferative problems, this kind of as polycythemia, platelet counts are frequently high. In essential thrombocythemia, platelet counts might be greater than 1,000,000/ L.